Corcept Therapeutics
CORT
CORT
285 hedge funds and large institutions have $2.36B invested in Corcept Therapeutics in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 109 increasing their positions, 90 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
16% less capital invested
Capital invested by funds: $2.79B → $2.36B (-$437M)
21% less call options, than puts
Call options by funds: $65.5M | Put options by funds: $83M
Holders
285
Holding in Top 10
5
Calls
$65.5M
Puts
$83M
Top Buyers
| 1 | +$42.6M | |
| 2 | +$18.4M | |
| 3 | +$17.3M | |
| 4 |
Man Group
London,
United Kingdom
|
+$16.9M |
| 5 |
Cerity Partners
New York
|
+$15.2M |
Top Sellers
| 1 | -$41.3M | |
| 2 | -$27.2M | |
| 3 | -$15.2M | |
| 4 |
D.E. Shaw & Co
New York
|
-$13.2M |
| 5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$10.9M |